Outlook Therapeutics, Inc. (OTLK) Competitors & Peers
The 5 companies closest to Outlook Therapeutics, Inc. on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $523.91 | P/E 30.5RSI 70Cap 132.7 B |
| REGN | Peer | $808.05 | P/E 19.4RSI 83Cap 83.2 B |
| ARGX | Peer | $866.11 | P/E 33.0RSI 49Cap 54.2 B |
| RVMD | Peer | $206.97 | RSI 68Cap 44.4 B |
| CSLLY | Peer | $23.77 | P/E 15.4RSI 68Cap 45.5 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence